Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
12/07/2010 | US7846673 Blot analysis of urine/serum; proteoglycan-like domains; oncogenes; hybridomas |
12/07/2010 | US7846672 Method for detecting the affinity of folate receptor auto antibodies |
12/07/2010 | US7846671 Methods of screening for agents that modulate the interaction of RGS and Gαq and urinary incontinence |
12/07/2010 | US7846667 Using myeloblastosis oncogene expression profile as tool in detection of cell proliferative disorders associated with respiratory system |
12/07/2010 | US7846661 Methods of detecting an amplified nucleic acid |
12/07/2010 | US7846658 Homogeneous time-resolved energy transfer assay |
12/07/2010 | US7846656 For immobilization in polymer carriers of oligonucleotides, proteins, nucleic acids or any other molecules, which structure comprises active groups, including amino- or sulfhydryl groups; for microchips, dna sequencing |
12/07/2010 | US7846653 measuring the concentration of apoptosis-associated speck-like protein containing a caspase-associated recruitment domain (ASC); early detection |
12/07/2010 | US7846652 Using kinase activation/phosphorylation as diagnostic indication of receptor modulation; for treatment of cell proliferative and inflammatory disorders |
12/07/2010 | US7846453 activating tyrosine phosphorylation of ErbB4 in an ErbB4-expressing cell by administering to the cell a polypeptide comprising the amino acid sequence of neuregulin 3 |
12/07/2010 | US7846451 Chimeric outermembrane polypeptide for use as tool in diagnosis and treatment of parasitic infection |
12/07/2010 | US7846433 Methods of treating pre-eclampsia and eclampsia |
12/07/2010 | US7846412 Bioconjugated nanostructures, methods of fabrication thereof, and methods of use thereof |
12/07/2010 | US7846389 High throughput screen |
12/07/2010 | US7846384 automatic aspiration from tubes; bar codes |
12/07/2010 | US7846383 Includes a chromatographic medium that defines a detection zone that provides a signal (diazonium salt ) indicative of the presence or amount of bilirubin or urobilinogen; for testing a bodily fluid, such as urine, blood, mucous, saliva |
12/07/2010 | US7846315 Multicompartment apparatus for propagation and replication of preferential nucleotide sequences |
12/07/2010 | US7846312 Electrochemical cell connector |
12/07/2010 | US7845212 High pressure high temperature sagging tester |
12/07/2010 | US7845208 Apparatus and method for detecting volatile dissolved substance |
12/07/2010 | CA2617914C Method for distinguishing electrochemical sensors |
12/07/2010 | CA2542104C Method for the identification of epitopes related to immunogenicity in biopharmaceuticals |
12/07/2010 | CA2491692C Reagents and a method for saturation labelling of proteins |
12/07/2010 | CA2458360C Detection of transmembrane potentials by optical methods |
12/07/2010 | CA2448211C Nucleic acid detection method |
12/07/2010 | CA2438292C System for optimized control of multiple oxidizer feedstreams |
12/07/2010 | CA2434243C Novel proteome analysis method and devices therefor |
12/07/2010 | CA2417570C Tumor-specific t cell activation by peptide antigens |
12/07/2010 | CA2393958C Auxiliary sample supply for a clinical analyzer |
12/07/2010 | CA2384579C Early cancer tumor marker |
12/07/2010 | CA2380352C Electromagnetic analyzer of anisotropy in chemical organized systems |
12/07/2010 | CA2375968C Imaging the dopamine transporter to determine ad-hd |
12/07/2010 | CA2323576C Bacteria attenuated by a non-reverting mutation in each of the aroc, ompf and ompc genes, useful as vaccines |
12/07/2010 | CA2301301C Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detection |
12/07/2010 | CA2264925C Purification of antigen-specific t cells |
12/07/2010 | CA2153653C Growth differentiation factor-9 |
12/02/2010 | WO2010138979A1 Apparatus, pods and methods for processing expandable food materials |
12/02/2010 | WO2010138960A2 Methods and systems for single-molecule rna expression profiling |
12/02/2010 | WO2010138914A1 Sers-active particles or substances and uses thereof |
12/02/2010 | WO2010138871A1 Integrated microchip surface acoustic wave sensor system for detection of infectious agents |
12/02/2010 | WO2010138851A2 E-cadherin as a biomarker of gastroesophageal reflux disease |
12/02/2010 | WO2010138843A2 Acute lymphoblastic leukemia (all) biomarkers |
12/02/2010 | WO2010138839A2 Use of 2 anti-sparc antibodies to predict response to chemotherapy |
12/02/2010 | WO2010138826A1 Methods and compositions related to cellular assays |
12/02/2010 | WO2010138814A2 Disrupting fcrn-albumin interactions |
12/02/2010 | WO2010138803A2 Herv-k antigens, antibodies, and methods |
12/02/2010 | WO2010138797A1 Peptoid ligands for isolation and treatment of autoimmune t-cells |
12/02/2010 | WO2010138709A1 Anti-tnf induced apoptosis (atia) diagnostic markers and therapies |
12/02/2010 | WO2010138621A2 Diagnosing and treating iga nephropathy |
12/02/2010 | WO2010138618A1 Molecular predictors of fungal infection |
12/02/2010 | WO2010138591A1 Ccr3 and its ligands are therapeutic and diagnostic targets for neovascular age-related macular degeneration |
12/02/2010 | WO2010138550A1 Conjugated nanodelivery vehicles |
12/02/2010 | WO2010138527A1 Analytical methods for measuring synthetic progesterone |
12/02/2010 | WO2010138505A1 Method of monitoring erythropoiesis |
12/02/2010 | WO2010138474A1 Detection of antibody that binds to water soluble polymer-modified polypeptides |
12/02/2010 | WO2010138187A1 Scaffolded nucleic acid polymer particles and methods of making and using |
12/02/2010 | WO2010138141A1 Combination therapy for the treatment of multiple myeloma |
12/02/2010 | WO2010138136A1 Devices and methods for determining the length of biopolymers and distances between probes bound thereto |
12/02/2010 | WO2010137903A2 Method for screening for a drug candidate substance which inhibits target protein-protein interaction for developing a novel concept drug |
12/02/2010 | WO2010137873A2 Primer for the diagnosis of the new influenza a virus, probe, kit comprising same, and diagnosis method using the kit |
12/02/2010 | WO2010137807A2 Method for signal amplification during lateral-flow analysis |
12/02/2010 | WO2010137722A1 Method for screening of regenerative medicine |
12/02/2010 | WO2010137717A1 Method for highly sensitive detection of protein-protein interaction |
12/02/2010 | WO2010137671A1 Method for assessing lymph node metastasis of cancer or the risk thereof, and rapid assessment kit for said method |
12/02/2010 | WO2010137654A1 Pharmaceutical composition containing antagonist of egf family ligand as component |
12/02/2010 | WO2010137532A1 Detection method and quantification method of detection target |
12/02/2010 | WO2010137489A1 Glucose dehydrogenase having altered properties |
12/02/2010 | WO2010137471A1 Device for measuring amount of agglutinated blood cells and method for measuring amount of agglutinated blood cells |
12/02/2010 | WO2010137470A1 Device for measuring deformability and method for measuring deformability |
12/02/2010 | WO2010137454A1 Method for analyzing aqueous ammonium carbamate solution, and method for operating unreacted gas-absorption tank |
12/02/2010 | WO2010136996A2 Microflow analytical system |
12/02/2010 | WO2010136896A1 Assays for influenza virus hemagglutinins |
12/02/2010 | WO2010136780A1 Method to detect and sequence post translationally modified peptides |
12/02/2010 | WO2010136759A1 Method and system for analyzing calcium transients in coupled cells |
12/02/2010 | WO2010136712A1 Method for detecting target compounds on the basis of capillarity |
12/02/2010 | WO2010136706A1 Novel method for quantifying proteins by mass spectrometry |
12/02/2010 | WO2010136629A1 Methods for the diagnosis or prognosis of colorectal cancer |
12/02/2010 | WO2010136595A1 Chemical reagent for measuring the level of halogen agents, in particular in swimming-pool water and associated measurement method |
12/02/2010 | WO2010136581A1 Imaging method and use thereof |
12/02/2010 | WO2010136569A1 Modulators for her2 signaling in her2 expressing patients with gastric cancer |
12/02/2010 | WO2010136560A1 Means and methods for ovarian cancer prognosis |
12/02/2010 | WO2010136476A1 Extraneous agents testing |
12/02/2010 | WO2010136455A1 Methods and reagents for the quantitative determination of metabolites in biological samples |
12/02/2010 | WO2010136288A1 Assembly for the controlled feeding and delivery of a gas mixture into an analysis chamber |
12/02/2010 | WO2010136258A1 Method and apparatus for determining the chemical oxygen demand of a liquid sample in oxygen demand by means of an oxidative boron-doped diamond electrode |
12/02/2010 | WO2010136232A1 In vitro method suitable for patients suffering from cis for the early diagnosis or prognosis of multiple sclerosis |
12/02/2010 | WO2010136212A1 Lipoxygenase and its use in wound healing |
12/02/2010 | WO2010136163A1 Secernin-1 as a marker for cancer |
12/02/2010 | WO2010136059A1 Urinary gm2 activator protein as a marker of acute renal failure or the risk of developing acute renal failure |
12/02/2010 | WO2010135997A1 Application of gold nanoparticles bonded directly to luminol in immunoassay |
12/02/2010 | WO2010135978A1 Biosensor and usage thereof |
12/02/2010 | WO2010135834A1 Biosensors utilizing ink jet-printed biomolecule compatible sol gel inks and uses thereof |
12/02/2010 | WO2010135800A1 Inhibiting oxidation and immobilizing biomolecules on a hydrogen-terminated crystalline silicon substrate |
12/02/2010 | WO2010135781A1 Methods of treating diseases |
12/02/2010 | WO2010120391A9 Ultrasensitive detection of isotopes, chemical substances and biological substances using laser wave-mixing detectors |
12/02/2010 | WO2010118706A3 Method for obtaining novel derivatives of naphthalene for the in vivo diagnosis of alzheimer's disease |
12/02/2010 | WO2010116196A3 Diagnosisof and treatment gluten-induced autoimmune diseases |
12/02/2010 | WO2010115997A3 Method for determining survival prognosis of patients suffering from non-small cell lung cancer (nsclc) |
12/02/2010 | WO2010115843A3 Pharmaceutical composition |
12/02/2010 | WO2010115825A3 Modulation of adipose triglyceride lipase for prevention and treatment of cachexia, loss of weight and muscle atrophy and methods of screening therefor |